Ephedra Herb is an important crude drug which has been used in Chinese and Japanese traditional (Kampo) medicines. Although about 35 species belonging to the genus Ephedra are distributed in Eurasia, North America, and South America, only a few species contain pharmacologically active ephedrine alkaloids and are used for medicinal purposes. The Japanese Pharmacopoeia defines Ephedra Herb as dried aerial parts of Ephedra sinica, E. intermedia and E. equisetina.
Herb as dried aerial parts of Ephedra sinica, E. intermedia and E. equisetina.
2) Morphological and anatomical characteristics have long been investigated to identify and/or discriminate these species since Konoshima described the morphology of E. equisetina collected in China.
3) However, because of their relatively simple organization it is sometimes difficult to identify original species of Ephedra Herb, especially when they do not bear flowers or fruits. Chemical identification of Ephedra plants mainly based on their alkaloid compositions or HPLC fingerprints has also been attempted, 4) but such chemical traits are inevitably affected by environmental and intra-specific variations.
For correct identification of biological materials, DNA profiling (DNA-based polymorphic assay) has several advantages over morphological and chemical analyses because genotypes rather than phenotypes are directly assayed, and so that the results are not affected by environmental factors. Long et al. compared nucleotide sequences of intergenic transcribed spacer (ITS) 1 and ITS2 of nuclear ribosomal DNA (rDNA) and of the chloroplast trnL-trnF region including trnL intron, 3Ј-exon of trnL, and trnL/trnF spacer from eight Ephedra species. 5) They found that the ITS sequence of E. sinica was identical with that of E. intermedia, whereas there were several polymorphic sites between these species and E. przewalskii. However, most of these polymorphic sites were later found to be subjected to intra-specific variation within either E. intermedia or E. przewalskii. 6) As for the chloroplast genome there were no polymorphic nucleotide sites in the trnL intron among E. sinica, E. intermedia and E. przewalskii. The only difference in these species was that two nucleotide deletions were present in the trnL/trnF spacer of E. sinica. 5) Thus, neither ITS of rDNA nor the trnL-trnF region is suitable as a DNA marker to identify medicinal Ephedra species by itself.
The chlB gene encodes a subunit B of light-independent photochlorophyllide reductase that catalyzes reduction of protochlorophyllide to chlorophyllide in chlorophyll biosynthesis, and is located in the chloroplast genome of gymnosperms, algae and photosynthetic bacteria but not in angiosperms. 7) The chlB has a higher evolutionary rate than the rbcL (large subunit of ribulose bisphosphate carboxylase/ oxygenase) gene which has been widely used as a molecular marker in plant phylogenetic analyses, 8) and might be suitable as a DNA marker for identification and/or discrimination of Ephedra species and the crude drugs derived therefrom.
In the present investigation we analyzed the nucleotide sequences of the chloroplast chlB gene amplified from the herbarium and crude drug specimens of Ephedra plants and established a novel protocol for DNA authentication of Ephedra Herb based on their chlB and rDNA ITS 1 sequences. Furthermore, we showed that the protocol could be successfully applied to identify the original species of Ephedra Herb obtained in the Chinese market.
MATERIALS AND METHODS

Herbarium and Crude Drug Specimens
Ten herbarium specimens and 22 crude drug specimens were selected from the collection of Central Research Laboratories, Tsumura & Co. (Table 1) . Their morphological features were re-evaluated based on the anatomical traits such as presence or absence of pith and of fiber bundles in the cortex and abundance of cuticles in the epidermis to confirm their species. The pharmacognostical evaluation of the samples was performed by Drs. H. Yamaji Preparation of DNA Total DNA was prepared from the powdered samples (about 40 mg) using a DNeasy Plant Mini Kit (Qiagen). DNA content in the preparation was estimated by a DyNA Quant 200 Fluorometer (Amersham) using calf thymus DNA (Sigma) as a standard.
Amplification of chlB Gene Polymerase chain reaction (PCR) primers (1F and 4R) were designed based on the chlB gene sequence of E. altissima retrieved from the DDBJ/ EMBL/Genebank Nucleotide Sequence Database (accession no. U21315) so that the whole open reading frame (ORF) of the chlB gene can be amplified. In addition, the 1.5 kb chlB ORF was also divided into four partially overlapped fragments (Fragment 1 to 4) of about 0.5 kb and each fragment was individually amplified using internal primers (2F, 3F, 4F, 1R, 2R, and 3R) designed based on the chlB sequence determined. The nucleotide sequences of the PCR primers were as follows: 1Fϭ5Ј-GTTTTCCCAGTCACGACATGAAATT-AGCTTATTGGAT-3Ј; 2Fϭ5Ј-GTTTTCCCAGTCACGAC-ATTCAAGCAGCAGATAGGAC-3Ј; 3Fϭ5Ј-GTTTTCCC-AGTCACGACTCGGTGAATCCTTTTGCTTC-3Ј; 4Fϭ5Ј-
GTTTTCCCAGTCACGACACTGTTGTTTTTGGTGA-TGC-3Ј;
1Rϭ5Ј-ATTTAGGTGACACTATAGAATACCC-GATGATATTTACAGAAGG-3Ј; 2Rϭ5Ј-ATTTAGGTGA-CACTATAGAATACTGAAAACCAAACAGCTTGGG-3Ј; 3Rϭ5Ј-ATTTAGGTGACACTATAGAATACTCGTACCC-CATAAAAGGACG-3Ј; 4Rϭ5Ј-ATTTAGGTGACACTATA-GAATACCAATTGTAATCTTAACTACACCC-3Ј. The underlined sequence in the forward and reverse primers shows the M13 universal forward primer and SP6 primer sequence, respectively, for direct sequencing of the PCR products. The approximate positions where the primers anneal to the template DNA are shown in Fig. 1 .
The PCR mixture contained 10 mM Tris-HCl (pH 8.8), 25 mM potassium chloride, 5 mM ammonium sulfate, 2 mM magnesium sulfate, 0.2 mM each dNTP, 0.4 mM of each primer, 0.4 ng/ml template DNA and 0.02 unit/ml Taq DNA Polymerase (Roche). Amplification was carried out under the following conditions: precycling at 94°C for 3 min, 30 cycles of denaturation at 94°C for 30 s, annealing at 55°C for 30 s and elongation at 72°C for 1 min, and then final elongation at 72°C for 10 min. PCR products were detected by ethidium bromide staining following 2% agarose gel electrophoresis using 5 ml of the PCR mixture.
Sequencing of the PCR Products Usually a 10 ml aliquot of the PCR mixture was incubated with 5 ml of ExoSAP-IT solution (Amersham) at 37°C for 15 min and then at 80°C for 15 min. A 7 ml aliquot of the resulting mixture was used for sequencing reaction using Thermo Sequenase Primer Cycle Sequencing Kit (Amersham) and the nucleotide sequence was determined for both strands with DSQ-2000L (Shimadzu).
PCR-Restriction Fragment Length Polymorphism (RFLP) Analysis Usually a 5 ml aliquot of the PCR mixture was digested with 10 unit of Bcl I at 50°C for 1 h in a final volume of 10 ml. The digested fragments were separated by agarose gel electrophoresis followed by ethidium bromide staining.
Amplification and Sequence Determination of ITS1 of rDNA For PCR amplification of the 3Ј-end of the ITS1 region from Ephedra Herb obtained in the market, we used the following primers: ITS-Fϭ5Ј-GTTTTCCCAGTCACGACC-GGCGGACGCGGTT-3Ј; ITS-RϭATTTAGGTGACACTA-TAGAATACCCCCGCGGCCGACGA-3Ј. The underlined sequence in the forward and reverse primer shows the M13 universal forward primer and SP6 primer sequence, respectively, for direct sequencing of the PCR products. The ITS-F and ITS-R primers were designed to anneal at nucleotides 835 to 848 and 926 to 912, respectively, of the ITS1 region of E. intermedia (accession no. AY394070) and E. przewalskii (accession no. AY394072) and expected size of the PCR products is about 100 bp. PCR amplification and sequencing of the PCR products were carried out as described above for the chlB gene.
HPLC Analysis of Ephedrine Alkaloids Quantitative analysis of ephedrine alkaloids was performed according to The Japanese Pharmacopoeia.
2) Briefly, the powdered crude drug (ca. 0.5 g) was extracted with 20 ml of 50% methanol, and the filtrate was subjected to HPLC column (Develosil ODS-5, 4.6ϫ150 mm, Nomura Chemicals) with isocratic elution by 27 mM sodium lauryl sulfate/acetonitrile/phosphoric acid (640 : 360 : 1). Flow rate was 1.3 ml/min and the elution was monitored at 210 nm.
RESULTS
Sequence Analysis of the chlB Fragments Amplified from Medicinal Ephedra Species Ten herbarium specimens and 22 crude drug specimens of Ephedra sinica, E. intermedia, E. equisetina, and E. przewalskii whose identities were confirmed based on their morphological characteristics were sampled from the collection of Central Research Laboratories, Tsumura & Co.
PCR products containing the whole ORF of the chlB gene were amplified from some of the samples using a PCR primer set (1F and 4R) designed based on the chlB sequence of E. altissima, and their nucleotide sequences were determined. The sequences thus obtained were used for designing internal PCR primers. In some samples, DNA was highly degraded into small fragments and did not give a PCR product when DNA preparations from these samples were used as templates. In such cases the chlB gene was divided into four fragments (Fragment 1 to 4, as shown in Fig. 1 ) of about 500 bp, which were individually amplified using the internal primer sets and sequenced. The nucleotide sequence of the chlB was determined by aligning the sequences of the four fragments.
Comparison of the nucleotide sequences indicated that there are four genotypes in the chlB gene amplified from four Ephedra species as shown in Table 2 . All of the 14 samples identified as E. sinica exhibited Type S. The samples identified as E. intermedia (nine specimens) or E. przewalskii (four specimens) had the identical genotype, Type IP. In contrast, four of five E. equisetina specimens exhibited Type E1 and one revealed Type E2. E. equisetina specimens with Type E1 genotype were from either Xinjiang or Russia and that with Type E2 genotype was from Shaanxi. The chlB sequences of six other Ephedra species: E. campulopoda, E. gerardiana, E. minuta, E. pachyclada, E. procea, E. regerianaand were also determined to find that their chlB sequences were different from any of the above-mentioned genotypes, although identity of these species was not confirmed (data not shown).
Identification of E. sinica by PCR-RFLP Fragment 1 of the chlB comprises about 500 bp from the 5Ј-end of the gene (Fig. 1) . A Bcl I restriction site is present at nt. 243- 248 (from the 5Ј-end of the fragment) in this fragment from E. sinica. This site is Bcl I resistant in seven other Ephedra species so far examined (E. campulopoda, E. gerardiana, E. minuta, E. pachyclada, E. procea and E. regeriana) or deposited in the DNA database (E. altissima) due to transition from cytosine to thymine at nt. 267 ( Fig. 2A) . We amplified Fragment 1 from various Ephedra specimens and the PCR products were incubated with Bcl I. As shown in Fig. 2B , all the PCR products of Fragment 1 from E. sinica specimens were digested to two fragments of about 250 bp while the products from the other Ephedra species remained undigested. This protocol may provide us with a convenient method for identification of E. sinica without sequencing.
Authentication of Ephedra Herb Obtained in the Chinese Market It was shown that E. sinica and E. equisetina can be identified based on the chlB sequence while the nucleotide sequence of the chlB gene of E. intermedia is identical with that of E. przewalskii. However, a nucleotide substitution was reported to be present at nt. 884 in ITS1 of the ribosomal DNA between these two species.
6) Therefore, we examined DNA authentication of 21 Ephedra Herb samples obtained in the Chinese market by analyzing the nucleotide sequences of both chlB and ITS1. Because E. przewalskii was practically devoid of ephedrine alkaloids, we also analyzed ephedrine alkaloid contents in these crude drug samples (Table 3) . Of the 21 samples nine were identified as E. sinica and three as E. equisetina based on their chlB sequence type. The rest of the samples were identified as either E. intermedia or E. przewalskii because their chlB sequence exhibited Type IP. The nucleotide sequences of the ITS1 region were analyzed for these samples, and seven were identified as E. intermedia and two as E. przewalskii based on the nucleotide at nt. 884 (adenine for E. intermedia and cytosine for E. przewalskii). The identification of these two samples as E. przewalskii was also confirmed based on their very low content of the ephedrine alkaloids. 
, E. przewalskii
The fragment 1 amplified from the samples was digested with Bcl I and separated by 4% agarose gel electrophoresis. For the samples, see Table 1 . 9) also reported that E. intermedia and E. przewarskii had the identical chloroplast rbcL sequence. They also showed that there is one nucleotide substitution between these two species and E. sinica whereas several substitutions between these three species and E. equisetina. Analysis of ITS 1 and ITS 2 of rDNA indicated that E. sinica and E. intermedia had the identical sequence while E. prezewalskii had several nucleotide sites different from E. sinica and E. intermedia, although there are some intra-specific variations in E. intermedia and E. przewalskii. 5, 6) All of these results as well as our results on the chlB sequences indicated that E. sinica, E. intermedia and E. przewalskii are phylogenetically close to each other while E. equisetina is an outgroup of the four Ephedra species.
The present investigation showed that E. sinica and E. equisetina can be identified based on the chlB sequence by direct sequencing. E. sinica might also be able to be distinguished from other species by PCR-RFLP analysis. In contrast, E. intermedia cannot be identified because this species had the identical chlB sequence as E. przewalskii. Sequence analysis of rDNA of E. intermedia and E. przewalskii revealed that these two species could be discriminated based on the nucleotide at nt. 884 (adenine in E. intermedia and cytosine in E. przewalskii) of the ITS 1 region. 6) Therefore, medicinal Ephedra species can be identified by analyzing nucleotide sequences of both chlB and ITS1 regions. We successfully applied this strategy to Ephedra Herb obtained in the Chinese market.
In conclusion, we have shown that the DNA profiling is a powerful tool for identification of the original species of Ephedra Herb. Direct sequencing of the Fragment 1 of the chlB sequence (or alternatively PCR-RFLP analysis of Fragment 1 for E. sinica) will lead to identification of E. sinica and E. equisetina. Determination of the nucleotide at nt 884 in the ITS1 of the rDNA will then allow us clear identification of E. intermedia.
